The specific effects of different medication storage systems on medication safety should now be studied. 1. National Patient Safety Agency (2010). Rapid Response Report. Reducing harm from
omitted and delayed medicines in hospital. NPSA/2010/RRR009. London. 2. McLeod MC, Barber N and Franklin BD (2013). Methodological variations and their effects on reported medication administration error rates. BMJ Quality and Safety published online first 16 January 2013, doi:10.1136/bmjqs-2012-001330. Ellen Koster, Joelle Walgers, Nina Winters, Marcel Bouvy Utrecht Institute of Phamaceutical Sciences, Utrecht, Utrecht, The Netherlands The aim of this study was to investigate how closely the recommendations for safe oral MTX dispensing are followed by Dutch community pharmacists Sunitinib and pharmacy technicians. For six of the eleven recommendations, Obeticholic Acid cell line adherence was more than 75% for both pharmacists and pharmacy technicians. The notation of the day of intake on the medication label increased significantly between
2008 to 2010 (p < 0.001). Dutch community pharmacies were able to implement the national recommendations for MTX dispensing and are adherent to most of them. Due to increased prescribing of oral methotrexate (MTX) for autoimmune disorders such as rheumatoid arthritis (RA) and psoriasis, the number of MTX users has increased during the past years. MTX is generally safe in low doses, however serious side effects and toxicity can occur in case of overdosing. Serious events, including fatal incidents with MTX, have been reported in several countries. Medication errors related to MTX can occur during all phases of use, but it has been shown that these errors often result from confusion about dosing schedules. Because of the narrow therapeutic range
and potential risks of incorrect use, vigilance is required when dispensing MTX. In 2009, the Royal Dutch Pharmacy Society published recommendations for safe MTX dispensing in community pharmacies (e.g. clearly note dosage and day of use on the medication label). Our aim was to examine pharmacies’ adherence to these recommendations. Pharmacies were recruited through the Utrecht Pharmacy Practice Network for Education and Research (UPPER) Janus kinase (JAK) network. This network consists of community pharmacies that regularly participate in research and traineeships for pharmacy students. Approximately 900 community pharmacists received an e-mail invitation to participate in this study. After four weeks, 78 pharmacists had responded positively and were included. The study consisted of two parts; first, we conducted interviews (a structured interview questionnaire) with the whole pharmacy team to assess self-reported adherence to the national MTX dispensing recommendations (Table 1), and second, implementation of working procedures to ensure safe MTX dispensing was assessed by examining pharmacy dispensing records.